Final Agenda

Saturday, January 26, 2019
7:00 AM - 8:00 AM Breakfast buffet and registration-Exhibits open
8:00 AM - 8:10 AM Welcome and Faculty Introduction
Hope S. Rugo, MD-Regional Director, Professor of Medicine, Director, Breast Oncology and Clinical Trials Education, University of California San Francisco, Helen Diller Family Comprehensive Cancer Center
8:10 AM - 8:45 AM Updates in HER2 targeted therapy: post neoadjuvant, duration, optimal therapy, new agents, sequencing, cardiac toxicity
Melanie Majure, MD – Assistant Professor, University of California San Francisco
8:45 AM - 9:20 AM Molecular signatures for prognosis, prediction and resistance; genomic testing in metastatic disease, blood versus tumor
Mark Pegram, MD – Director, Breast Cancer Oncology Program at Stanford Women’s Cancer Center, Susy Yuan-Huey Hung Professor of Oncology, and Co-Director Molecular Therapeutics Program, Stanford Cancer Institute
9:20 AM - 9:55 AM Advances in hormone therapy: prevention and treatment
Virginia Kaklamani, MD, DSc, Professor of Medicine, Associate Director Clinical Research Leader, Breast Oncology Program, UT Health San Antonio MD Anderson Cancer Center
9:55 AM - 10:15 AM Panel Q and A, Presentation of interesting and challenging cases
10:15 AM - 10:45 AM BREAK
10:45 AM - 11:15 AM Advances in loco-regional therapy
Joanna Yang, MD, MPH – Assistant Professor, Department of Radiation Oncology, University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center
11:15 AM - 11:45 AM Survivorship and breast cancer in older patients
Michelle E. Melisko, MD – Professor of Medicine, University of California San Francisco, Helen Diller Family Comprehensive Cancer Center
11:45 AM - 12:20 PM What’s new in the treatment of TNBC? (immunotherapy and novel agents)
Melinda L. Telli, MD – Associate Professor of Medicine (Oncology) at the Stanford University Medical Center
12:20 PM - 12:45 PM Q and A, Presentation of interesting and challenging cases
12:45 PM - 1:00 PM Summary of key takeaway points
Hope S. Rugo, MD-Regional Director, Professor of Medicine, Director, Breast Oncology and Clinical Trials Education, University of California San Francisco, Helen Diller Family Comprehensive Cancer Center

Any questions? Please email us today.

You are connected to the secure server. You are connected to the secure server.
 
 
 
Registration Powered By eShow